Publications by authors named "B E Sumpio"
Article Synopsis
- * The evaluation highlighted areas where the AI struggled, particularly in interpreting complex medical scenarios and demonstrated issues with context understanding, leading to errors in 27% of cases.
- * Although GPT-4 showed potential for clinical relevance, further scrutiny of its reasoning and accuracy is necessary before fully relying on it in a medical setting.
Chronic wounds affect ~2% of the U.S. population and increase risks of amputation and mortality.
View Article and Find Full Text PDFEndovascular stenting of external iliac vein injury during anterior spine exposure.
J Vasc Surg Cases Innov Tech
August 2024
Anterior lumbar interbody fusion (ALIF) is a standard approach for the surgical management of patients with severe degenerative disease at the L4-L5 and lumbosacral (L5-S1) levels. ALIF is performed through retroperitoneal exposure but harbors a small risk of major vascular injury. In this case, we describe an emergent endovascular repair of an external iliac vein injury that occurred during ALIF with long-term follow-up.
View Article and Find Full Text PDFUse of Serum Protein Measurements as Biomarkers that Can Predict the Outcome of Diabetic Foot Ulceration.
Adv Wound Care (New Rochelle)
September 2024
Article Synopsis
- The study analyzed serum samples from diabetic patients with diabetic foot ulcers (DFU) to identify proteins that could predict healing and serve as biomarkers for treatment.
- Among the findings, certain interleukins (IL-10, IL-4, IL-5, IL-6, and IL-13) were elevated in patients who healed, while others (Fractalkine, IL-8, and TNFα) were higher in those who did not.
- IL-10 emerged as the strongest predictor for healing, suggesting that measuring multiple serum proteins could enhance clinical management of DFU compared to using single biomarkers.
Use of Therapeutic RNAs to Accelerate Wound Healing in Diabetic Rabbit Wounds.
Adv Wound Care (New Rochelle)
September 2024
Diabetes mellitus (DM) affects over 422 million people globally. Patients with DM are subject to a myriad of complications, of which diabetic foot ulcers (DFUs) are the most common with ∼25% chance of developing these wounds throughout their lifetime. Currently there are no therapeutic RNAs approved for use in DFUs.
View Article and Find Full Text PDF